91 related articles for article (PubMed ID: 8233078)
1. Scyliorhinin-I and -II induce reciprocal hindlimb scratching in mice: differentiation of spinal and supraspinal neurokinin receptors in vivo.
Raffa RB; Martinez RP; Connelly CD
Neurosci Lett; 1993 Aug; 158(1):87-91. PubMed ID: 8233078
[TBL] [Abstract][Full Text] [Related]
2. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
Picard P; Regoli D; Couture R
Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
[TBL] [Abstract][Full Text] [Related]
4. A selective and extremely potent antagonist of the neurokinin-1 receptor.
Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M; Terenius L
Brain Res; 1992 Oct; 593(2):319-22. PubMed ID: 1280526
[TBL] [Abstract][Full Text] [Related]
5. Tachykinins alter inositol phosphate formation, but not cyclic AMP levels, in primary cultures of neonatal rat spinal neurons through activation of neurokinin receptors.
Parsons AM; el-Fakahany EE; Seybold VS
Neuroscience; 1995 Oct; 68(3):855-65. PubMed ID: 8577379
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological effects of tachykinins and capsaicin on guinea-pig bronchial parasympathetic ganglion neurones.
Myers AC; Undem BJ
J Physiol; 1993 Oct; 470():665-79. PubMed ID: 7508508
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular responses to intrathecal neuropeptide gamma in conscious rats: receptor characterization and mechanism of action.
Poulat P; de Champlain J; Couture R
Br J Pharmacol; 1996 Jan; 117(2):250-7. PubMed ID: 8789376
[TBL] [Abstract][Full Text] [Related]
8. Behavioral activation of neurokinin-1 agonists in relation to enzymatic degradation in the spinal cord.
Sakurada T; Yogo H; Tan-No K; Sakurada S; Kisara K
J Pharm Sci; 1994 Jan; 83(1):2-4. PubMed ID: 7511162
[TBL] [Abstract][Full Text] [Related]
9. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
Tauer U; Zhao Y; Hunt SP; Culman J
Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
[TBL] [Abstract][Full Text] [Related]
10. N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice.
Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K; Ohba M; Terenius L
Life Sci; 1990; 47(20):PL109-13. PubMed ID: 1701844
[TBL] [Abstract][Full Text] [Related]
11. Neurokinin peptides and neurokinin receptors as potential therapeutic intervention targets of basal ganglia in the prevention and treatment of Parkinson's disease.
Chen LW; Yung KK; Chan YS
Curr Drug Targets; 2004 Feb; 5(2):197-206. PubMed ID: 15011953
[TBL] [Abstract][Full Text] [Related]
12. Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.
Sakurada T; Katsuyama S; Sakurada S; Inoue M; Tan-No K; Kisara K; Sakurada C; Ueda H; Sasaki J
Br J Pharmacol; 1999 Aug; 127(7):1712-8. PubMed ID: 10455330
[TBL] [Abstract][Full Text] [Related]
13. Intracerebroventricular responses to neuropeptide gamma in the conscious rat: characterization of its receptor with selective antagonists.
Picard P; Couture R
Br J Pharmacol; 1996 Jan; 117(2):241-9. PubMed ID: 8789375
[TBL] [Abstract][Full Text] [Related]
14. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
Broccardo M; Improta G; Tabacco A
Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice.
Sakurada T; Manome Y; Katsumata K; Tan-No K; Sakurada S; Ohba M; Kisara K
Eur J Pharmacol; 1994 Aug; 261(1-2):85-90. PubMed ID: 7528145
[TBL] [Abstract][Full Text] [Related]
16. Phosphoramidon potentiates mammalian tachykinin-induced biting, licking and scratching behaviour in mice.
Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K
Pharmacol Biochem Behav; 1990 Dec; 37(4):779-83. PubMed ID: 1709505
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of tachykinin NK-1 and NK-3 receptor binding sites in the spinal cord of spontaneously hypertensive rat: impact on the autonomic control of blood pressure.
Cloutier F; Ongali B; Deschamps K; Brouillette J; Neugebauer W; Couture R
Br J Pharmacol; 2006 May; 148(1):25-38. PubMed ID: 16491095
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.
Bellucci F; Carini F; Catalani C; Cucchi P; Lecci A; Meini S; Patacchini R; Quartara L; Ricci R; Tramontana M; Giuliani S; Maggi CA
Br J Pharmacol; 2002 Jan; 135(1):266-74. PubMed ID: 11786503
[TBL] [Abstract][Full Text] [Related]
19. Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat.
Humpel C; Saria A
Neurosci Lett; 1993 Jul; 157(2):223-6. PubMed ID: 7694197
[TBL] [Abstract][Full Text] [Related]
20. Selective agonists for receptors of substance P and related neurokinins.
Regoli D; Dion S; Rhaleb NE; Rouissi N; Tousignant C; Jukic D; D'Orleans-Juste P; Drapeau G
Biopolymers; 1989 Jan; 28(1):81-90. PubMed ID: 2470440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
